Neurotech Pharmaceuticals, Inc. has announced that they have enrolled the first patient in their multicenter Phase 2 clinical trial of NT-503 Encapsulated Cell Therapy (ECT) for the long-term treatment of wet macular degeneration (AMD). NT-503 is a unique vascular endothelial growth factor (VEGF) receptor protein continuously produced by Neurotech’s versatile ECT implant. “This landmark proof-of-concept [Read More]
Author: droberts
New Book On Eye Nutrition Answers Common Questions
Leading nutrition expert Jeffrey Anshel, OD, FAAO, has just published a new book titled “What You Must Know about Food and Supplements for Optimal Vision Care.” It is a practical guide to diets, supplements and lifestyles for peak ocular health, with excellent information about how to integrate supplements with mainstream medical treatments whenever appropriate. Dr. [Read More]
Preventative Eye Care Should Be At The Political Forefront
Guest Editorial by Ellen Troyer, MT, MA CEO, Biosyntrx The Affordable Care Act (ACA) doesn’t pay for Medicare and Medicaid routine eye exams for disease prevention but it does cover diagnosed disease identified in self-pay routine eye exams. This leaves an ever-growing segment of the adult US population with limited access to eye care professionals, [Read More]
Driving Still Possible For Some With Low Vision
Low vision doesn’t have to mean losing the privilege of driving a car. That’s the position of the International Academy of Low Vision Specialists (IALVS), an organization committed to helping people realize there is “life after vision loss.” As part of fulfilling that mission, IALVS provides information on Department of Motor Vehicle (DMV) vision requirements in all 50 states, [Read More]
Top 10 Misconceptions About Blindness
Pop quiz from Orcam . . . You’re at a dinner party and your host introduces you to one of the other guests in attendance. The other guest is holding a white cane and wearing sunglasses so you come to the conclusion that they are blind. What do you do? A. Begin conversing with the [Read More]